Interpace Biosciences Inc
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $15.2M | $602.0K | $8.3M | $23.1M | $45.6M | $52.8M | $64.3M | $62.7M |
| Accounts Receivable | $3.4M | $2.2M | $2.8M | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $19.8M | $4.2M | $19.2M | $44.9M | $62.7M | $71.6M | $80.4M | $80.7M |
| Property, Plant & Equipment | $654.0K | $929.0K | $1.5M | $1.8M | $1.6M | $2.4M | $2.5M | $3.9M |
| Goodwill | — | — | $0 | $15.5M | $0 | $2.5M | $18.9M | $24.0M |
| Intangible Assets (Excl. Goodwill) | $33.1M | $36.4M | $43.5M | $47.3M | — | $0 | $7.3M | $8.4M |
| Total Assets | $36.6M | $25.1M | $64.7M | $115.2M | $69.1M | $78.4M | $113.4M | $124.4M |
| Liabilities | ||||||||
| Accounts Payable | $391.0K | $2.3M | $1.6M | $2.2M | $2.2M | $3.4M | $4.1M | $3.3M |
| Total Current Liabilities | $8.1M | $16.2M | $23.4M | $33.6M | $31.4M | $36.4M | $46.1M | $43.3M |
| Long-Term Debt | — | $7.9M | $7.2M | $27.2M | — | — | — | — |
| Total Liabilities | $13.7M | $35.2M | $54.7M | $95.8M | $36.6M | $42.8M | $53.9M | $54.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-131.8M | $-119.6M | $-111.3M | $-99.9M | $-83.8M | $-79.3M | $-53.7M | $-41.8M |
| Total Stockholders' Equity | $22.9M | $-10.1M | $10.1M | $19.4M | $32.5M | $35.6M | $59.5M | $69.5M |